A 10-year follow-up study found that partial meniscectomy did not improve symptoms or knee function when compared with sham ...

A major 10-year clinical trial is turning one of the world’s most common knee surgeries on its head. Researchers found that ...

Topline results for the randomized portion of PALISADE-4 are expected in the second quarter of 2026SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage ...

GLP-1RAs significantly reduce major cardiovascular events, mortality, and other clinically significant complications in ...

Artiva Biotherapeutics (ARTV) is maintained as a "Buy," driven by FDA alignment for a single phase 3 trial of AlloNK plus ...

PNAS recently published credulous nonsense about acupuncture so bad that I thought it couldn't be topped. "Hold my beer!" ...

Current Infectious Disease Society of America guidelines for the treatment of invasive candidiasis recommend a minimum ...

FDA drug approvals are reshaping biotech stocks—track key decisions, FDA leadership turmoil, and volatility. Click for a look ...

Experts are already treating addicted people with at-home neuromodulation devices to control cravings, and the future is ...

David Toro-Tobon and colleagues argue that “clinician in the loop” is shifting responsibility for AI safety from developers ...

The ENO Breathe programme can improve HRQOL, breathlessness, anxiety, and respiratory symptoms in people with long COVID and ...